Вернуться к исследованию
clinomir.ruПамятка для лечащего врача · 19.11.2026

Пациент интересуется клиническим исследованием. Ниже — сведения из открытого реестра разрешений. Решение об участии принимают пациент, вы и врач-исследователь центра после скрининга.

Phosphocreatine sodium tetrahydrate after anaesthesia induction; 5% Glucose after anaesthesia induction; Phosphocreatine sodium tetrahydrate added to cardioplegia; 5% Glucose; Phosphocreatine sodium tetrahydrate after heart recovery; 5% Glucose after heart recovery; Phosphocreatine sodium tetrahydrate after ICU admission; 5% Glucose after ICU admission

Myocardial Protection With Phosphocreatine in High-RIsk Cardiac SurgEry Patients: a Single-center Randomised Double-blind Placebo-controlled Exploratory Pilot Clinical Trial

Номер протокола
PCr-in-CS
Фаза
Фаза III
Статус
Завершено
Спонсор
Meshalkin Research Institute of Pathology of Circulation
Участников по плану
120 (во всех странах)
Сроки
01.06.2016 — 01.05.2021

Простыми словами

Цель исследования

There is evidence on the role of the phosphotransfer system in the energy metabolism of the heart, with altered energetics playing an important role in the mechanisms of heart failure. Phosphocreatine plays an important part in the energy heart system. The investigators have just performed a systematic review and meta-analysis of randomized controlled trials (RCTs) and matched studies that compared phosphocreatine with placebo or standard treatment in patients with coronary artery disease or chronic heart failure or in those undergoing cardiac surgery. Patients receiving phosphocreatine had lower all-cause mortality as well as improved cardiac outcomes when compared to the control group, however, the quality of the included studies was low. Thus, the investigators plan to conduct an exploratory high quality RCT to investigate whether providing phosphocreatine compared to placebo improve…

Центры

Центры в реестре не указаны.

Как направить пациента

Страница исследования: https://clinomir.ru/trials/17263/

Источник: открытый реестр разрешений на клинические исследования. Сведения сведены порталом «Клиномир» и могут отставать от реестра; актуальность уточняйте в центре.

Релиз 26 · сборка 2026-11-13_1416 (082bfa7)